Stocks News

LAST PRICE
82.3600
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
62.4000/ 1
Ask / Lots
119.0400/ 2
Open / Previous Close
--- / 82.3600
Day Range
---
52 Week Range
Low 56.6100
High 83.8300
Volume
6
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 15, 2024
- Prestige Consumer Healthcare Insider Sold Shares Worth $2,024,499, According to a Recent SEC Filing, from 3:27AM ET on Friday Nov 15, 2024 by MT Newswires
  3:27AM ET on Friday Nov 15, 2024 by MT Newswires
  Companies Mentioned: PBH
  03:27 AM EST, 11/15/2024 (MT Newswires) -- Christine Sacco, Chief Financial Officer, on November 12, 2024, sold 24,686 shares in Prestige Consumer Healthcare (PBH) for $2,024,499. Following the Form 4 filing with the SEC, Sacco has control over a to...
Nov 11, 2024
- DJ Prestige Consumer Hlthcr Is Maintained at Buy by DA Davidson, from 11:48AM ET on Monday Nov 11, 2024 by Dow Jones
  11:48AM ET on Monday Nov 11, 2024 by Dow Jones
  Companies Mentioned: PBH
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/PBH/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 11, 2024 11:48 ET (16:48 GMT)
Nov 7, 2024
- Prestige Consumer Healthcare's Fiscal Q2 Earnings Rise, Revenue Falls; 2025 Outlook Reiterated, from 9:05AM ET on Thursday Nov 07, 2024 by MT Newswires
  9:05AM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: PBH
  09:05 AM EST, 11/07/2024 (MT Newswires) -- Prestige Consumer Healthcare (PBH) reported fiscal Q2 earnings Thursday of $1.09 per diluted share, up from $1.07 a year earlier. Analysts polled by Capital IQ expected $1.08. Total revenue for the quarter ...
- -- Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE Reports Q2 EPS $1.09, vs. Street Est of $1.08, from 6:03AM ET on Thursday Nov 07, 2024 by MT Newswires
  6:03AM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: PBH
  06:03 AM EST, 11/07/2024 (MT Newswires) -- ...
- -- Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE Posts Q2 Revenue $283.8M, vs. Street Est of $282.8M, from 6:02AM ET on Thursday Nov 07, 2024 by MT Newswires
  6:02AM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: PBH
  06:02 AM EST, 11/07/2024 (MT Newswires) -- ...

Nov 14, 2024
- Emergent Biosolutions Insider Sold Shares Worth $272,750, According to a Recent SEC Filing, from 4:21PM ET on Thursday Nov 14, 2024 by MT Newswires
  4:21PM ET on Thursday Nov 14, 2024 by MT Newswires
  Companies Mentioned: EBS
- Sector Update: Health Care Stocks Advance Pre-Bell Thursday, from 9:20AM ET on Thursday Nov 14, 2024 by MT Newswires
  9:20AM ET on Thursday Nov 14, 2024 by MT Newswires
  Companies Mentioned: IBB, XLV, CLPT, PTCT, BGNE
- DJ PTC Therapeutics Is Maintained at Equal-Weight by Barclays, from 9:20AM ET on Thursday Nov 14, 2024 by Dow Jones
  9:20AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: PTCT
- Sector Update: Health Care, from 8:51AM ET on Thursday Nov 14, 2024 by MT Newswires
  8:51AM ET on Thursday Nov 14, 2024 by MT Newswires
  Companies Mentioned: CLPT, PTCT
- Top Premarket Gainers, from 7:56AM ET on Thursday Nov 14, 2024 by MT Newswires
  7:56AM ET on Thursday Nov 14, 2024 by MT Newswires
  Companies Mentioned: BTCS, CLPT, BTCT, PTCT, TLN
- ClearPoint Neuro Says FDA Granted Marketing Authorization for SmartFlow Neuro Cannula, from 4:54AM ET on Thursday Nov 14, 2024 by MT Newswires
  4:54AM ET on Thursday Nov 14, 2024 by MT Newswires
  Companies Mentioned: CLPT, PTCT
- PTC Therapeutics Receives FDA Acceslerated Approval for Rare Brain Disease Deficiency Treatment, from 3:38AM ET on Thursday Nov 14, 2024 by MT Newswires
  3:38AM ET on Thursday Nov 14, 2024 by MT Newswires
  Companies Mentioned: PTCT
Nov 13, 2024
- PTC Therapeutics Announces FDA Approval of AADC Deficiency Gene Therapy, from 6:03PM ET on Wednesday Nov 13, 2024 by PR Newswire
  6:03PM ET on Wednesday Nov 13, 2024 by PR Newswire
  Companies Mentioned: PTCT
- PTC Therapeutics Announces FDA Approval of AADC Deficiency Gene Therapy, from 6:02PM ET on Wednesday Nov 13, 2024 by Dow Jones
  6:02PM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: PTCT
- Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference, from 4:07PM ET on Wednesday Nov 13, 2024 by Dow Jones
  4:07PM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: AMPH

Prestige Consumer Healthcare Inc
NYSE:PBHUnited States

Search Criteria

Nov 15, 2024

Prestige Consumer Healthcare Insider Sold Shares Worth $2,024,499, According to a Recent SEC Filing, from 3:27AM ET on Friday Nov 15, 2024 by MT Newswires

Nov 11, 2024

DJ Prestige Consumer Hlthcr Is Maintained at Buy by DA Davidson, from 11:48AM ET on Monday Nov 11, 2024 by Dow Jones

Nov 7, 2024

Prestige Consumer Healthcare's Fiscal Q2 Earnings Rise, Revenue Falls; 2025 Outlook Reiterated, from 9:05AM ET on Thursday Nov 07, 2024 by MT Newswires

-- Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE Reports Q2 EPS $1.09, vs. Street Est of $1.08, from 6:03AM ET on Thursday Nov 07, 2024 by MT Newswires

-- Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE Posts Q2 Revenue $283.8M, vs. Street Est of $282.8M, from 6:02AM ET on Thursday Nov 07, 2024 by MT Newswires

Peers Headlines

Nov 14, 2024

Emergent Biosolutions Insider Sold Shares Worth $272,750, According to a Recent SEC Filing, from 4:21PM ET on Thursday Nov 14, 2024 by MT Newswires

Sector Update: Health Care Stocks Advance Pre-Bell Thursday, from 9:20AM ET on Thursday Nov 14, 2024 by MT Newswires

DJ PTC Therapeutics Is Maintained at Equal-Weight by Barclays, from 9:20AM ET on Thursday Nov 14, 2024 by Dow Jones

Sector Update: Health Care, from 8:51AM ET on Thursday Nov 14, 2024 by MT Newswires

Top Premarket Gainers, from 7:56AM ET on Thursday Nov 14, 2024 by MT Newswires

ClearPoint Neuro Says FDA Granted Marketing Authorization for SmartFlow Neuro Cannula, from 4:54AM ET on Thursday Nov 14, 2024 by MT Newswires

PTC Therapeutics Receives FDA Acceslerated Approval for Rare Brain Disease Deficiency Treatment, from 3:38AM ET on Thursday Nov 14, 2024 by MT Newswires

Nov 13, 2024

PTC Therapeutics Announces FDA Approval of AADC Deficiency Gene Therapy, from 6:03PM ET on Wednesday Nov 13, 2024 by PR Newswire

PTC Therapeutics Announces FDA Approval of AADC Deficiency Gene Therapy, from 6:02PM ET on Wednesday Nov 13, 2024 by Dow Jones

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference, from 4:07PM ET on Wednesday Nov 13, 2024 by Dow Jones